1.. Introduction {#S1}
================

Antibiotic-resistant pathogens are major causes of morbidity and mortality in healthcare settings, where Methicillin-resistant *Staphylococcus aureus* (MRSA), first identified in the 1960s and common in hospitals by the 1980s ([@R14]; [@R16]), increased in prevalence ([@R14]; [@R10]) through 2005. Since then, rates of hospital associated MRSA infections and colonization have been on the decline across the United States ([@R1]; [@R12]).

As with national trends, rates of MRSA healthcare-associated infections in Department of Veterans Affairs (VA) hospitals have declined since late 2007. Some attribute this decline to VA's MRSA Prevention Initiative which comprised universal nasal surveillance for MRSA colonization, contact precautions for patients who were identified carriers of MRSA, an emphasis on hand hygiene, and an institutional culture change which placed the responsibility of infection control on everyone who had contact with patients. The MRSA Prevention Initiative launched nationally in hospitals October 1, 2007 ([@R7]), and extended it to all VA nursing homes on January 1, 2009 ([@R2]). Although VA MRSA infection rates dropped following VA's MRSA Prevention Initiative, experts debate the extent to which the MRSA Prevention Initiative contributed to those rate reductions ([@R4]; [@R8]; [@R13]). This disagreement has prompted further debates about the role of mandated contact precautions ([@R15]; [@R17]).

The epidemiology of MRSA infection has been studied across a broad range of healthcare settings, yet we have limited understanding of the heterogeneity in MRSA transmission ([@R11]). Understanding variation in MRSA transmission is critical for identifying facility and patient characteristics that contribute to transmission, and for informing future interventions to control antibiotic resistant organisms. We conducted an epidemiological analysis of MRSA transmission in more than 230 facilities including acute care and nursing homes. The principal aims of this analysis were to better understand variation in MRSA transmission, within and between healthcare facility types, and to identify trends in the transmission rate immediately following implementation of the VA's MRSA Prevention Initiative. To our knowledge, this analysis, based on a mechanistic transmission model, represents the largest such analysis to date.

Previous analyses of the MRSA Prevention Initiative focused on MRSA healthcare associated infections but neglected to investigate transmission or account for admission prevalence, length of stay, and decolonization (clearance); important factors underlying the epidemiology of MRSA in healthcare facilities. To provide new and more comprehensive insights into MRSA transmission in VA, we disentangle the effects of length of stay, admission prevalence, transmission rate, clearance rate, and imperfect testing to better understand the variability in MRSA transmission dynamics in VA hospitals and nursing homes. We also estimate trends in the per-capita transmission rate to estimate changes in transmission following implementation of the MRSA Prevention Initiative.

2.. Methods {#S2}
===========

2.1.. Data {#S3}
----------

We analyzed electronic health record data from individuals admitted to a VA hospital between October 1, 2007 (when VA launched the initiative in its hospitals) and July 1, 2011; or to a VA nursing home from January 1, 2009 (when VA launched the initiative began in its nursing homes) and December 31, 2010. The different times at which the MRSA Prevention Initiative was implemented in hospitals and nursing homes, together with the completeness of the MRSA surveillance data available in our study cohort led to differing follow-up times between hospitals and nursing homes. Data included facility and patient identifier, date and time of admission and discharge, and MRSA surveillance test results.

There were 145 hospitals with patient data during the study period. Of these, we excluded 7 hospitals that had a mean length of stay \> 20 days, 6 additional hospitals with less than 1% of patients having at least one surveillance test, and 3 more hospitals having a mean daily census of under 3 patients per day. Lastly, there were 7 hospitals with incomplete data which were excluded from this analysis, resulting in a total of 23 (16%) hospitals excluded leaving 122 hospitals for this analysis. From 136 nursing homes with patient data during the study period, we excluded 2 nursing homes having mean length of stay \<10 days, and 23 nursing homes with incomplete data, resulting in 25 (18%) nursing homes excluded leaving 111 nursing homes in this analysis.

2.2.. Model {#S4}
-----------

We extended our recently published dynamic transmission models ([@R19]; [@R9]) to allow for changes in patients' colonization status, and temporal trends in transmission, and to estimate key epidemiologic parameters. This extended model allowed for patients who acquired and lost colonization with MRSA both during hospitalizations and between consecutive admissions. We assumed there were no false positive surveillance tests, but false negatives were represented by probabilistic uncertainty on the patients' colonization status at the time of the negative test.

The key parameters ([Table 1](#T1){ref-type="table"}) include false negative probability, clearance rates both during admissions and between consecutive admissions, and intercept and slope for the log-transformed transmission rate. The intercept parameter corresponds with the *baseline* transmission rate (at the beginning of the study) while the slope indicates the temporal trend in the transmission rate over time. The *in-situ* probability is the probability that a patient is colonized at the beginning of the study period, which results from either an acquisition or an importation (MRSA colonized at the time of admission) prior to the beginning of the study. Below, we describe the implementation and the structure of the model in more detail.

The model was implemented within a Bayesian framework, depending on an *augmented* data set, *D*, which combined both observed data (i.e. admission, discharge and surveillance test times and results) and unobserved data (i.e. times of acquisition and clearance). We assumed that *D* was organized as a list of events ordered by their corresponding times, and we represented model parameters by *θ*. The likelihood of the data, *D*, given the model parameters is given by $$\pi(D\, \mid \,\theta) = \prod_{e \in D}\, g(e;\,\theta) \cdot h(t_{e},\, t_{e^{-}};\,\theta).$$

We define *t*~*e*~ and *t*~*e*^−^~ as the times of the events *e*, and the event prior, *e^−^*. The term *g*(*e*; *θ*) represents the contribution to the likelihood of event type *e*, while *h* (*t~e~*, *t*~e^−^~; *θ*) is the probability that no event is observed between times *t*~*e*~ and *t*~*e*^−^~, given by the formula $$h(t_{e},\, t_{e^{-}};\,\theta) = \text{exp}\left\{ {- \frac{U_{t_{e^{-}}} \cdot C_{t_{e^{-}}}}{N_{t_{e^{-}}}}\int_{t_{e^{-}}}^{t_{e}}\lambda(t)dt + \mathit{\eta}C_{t_{e^{-}}}(t_{e} - t_{e^{-}})} \right\}.$$

The number of uncolonized and colonized individuals at time *t* are given by *U*~*t*~ and *C*~*t*~, and *N*~*t*~ = *U~t~* + *C~t~* is the total number of patients at time *t*. The transmission rate parameter at time *t* is given by *λ* (*t*), and *η* denotes the constant rate of clearance for colonized patients in the facility.

We assumed that acquisitions in the hospital at time *t* per uncolonized individual occur at a rate of *λ*(*t*)·*C~t~*/*N~t~*, corresponding to a frequency-dependent transmission model. Since we were interested in estimating temporal trends in the transmission rate parameter, and because we require *λ*(*t*) ≥ 0, we assumed that *λ*(*t*) = exp(*λ~I~* + *λ*~*S*~*t*), where *λ~I~* and *λ~S~* are the intercept and slope respectively of the log-transmission rate. Consequently, the contribution of an acquisition event *e* to the likelihood is given by *g*(*e*; *θ*) = *λ*(*t~e~*)·*C~t~e^−^~~*/*N~t~e^−^~~*.

At the time of admission into the facility, patients were assumed to be either colonized or uncolonized. The probability of colonization at admission, or importation, depended on whether the admission was a first-admission, in which case the probability was represented by the *first-admission importation probability*, or whether the patient had been previously admitted. Colonization status between consecutive admissions was modeled as a two-state continuous-time Markov chain (CTMC). In particular, uncolonized patients were colonized at rate *α* and colonized individuals lost colonization at rate *γ*. From these two parameters, we defined first-admission importation probability as the steady-state fraction of individuals who were colonized between consecutive admissions *ν* = *α*/(*α* + *γ*).

We explicitly modeled first-admission importation *ν* and outpatient clearance *γ*, from which estimates of *α* were uniquely determined. Therefore, for a first-admission event, the contribution to the likelihood was given by $$g(e;\,\theta) = \left\{ \begin{array}{l}
{\mathcal{V},\quad{if}\, s(e) = 1} \\
{1 - \mathcal{V},\quad{if}\, s(e) = 0} \\
\end{array}\phantom{\}} \right.$$ where *s*(*e*) indicates that the patient corresponding with event *e* was colonized at time *t*~*e*~. For readmissions, the importation probability depended on patients' colonization status at prior discharge, denoted *e~d~*, and the time since prior discharge Δ*t* = *t~e~* -- *t~e~d~~*. Computing the probability of importation for readmissions required computing transition probabilities for the out-of-facility CTMC, which resulted in the contribution of a readmission to the likelihood given by $$g(e;\,\theta) = \left\{ \begin{array}{l}
{\mathcal{V}\left\lbrack {1 - \text{exp}\left\{ {- \Delta t\frac{\gamma}{1 - \mathcal{V}}} \right\}} \right\rbrack,{if}\, s(e) = 1,\quad s(e_{d}) = 0} \\
{\mathcal{V} + (1 - \mathcal{V})\left\lbrack {\text{exp}\left\{ {- \Delta t\frac{\gamma}{1 - \mathcal{V}}} \right\}} \right\rbrack,{if}\, s(e) = 1,\quad s(e_{d}) = 1} \\
{1 - \mathcal{V} + \mathcal{V}\left\lbrack {\text{exp}\left\{ {- \Delta t\frac{\gamma}{1 - \mathcal{V}}} \right\}} \right\rbrack,{if}\, s(e) = 0,\quad s(e_{d}) = 0} \\
{(1 - \mathcal{V})\left\lbrack {1 - \text{exp}\left\{ {- \Delta t\frac{\gamma}{1 - \mathcal{V}}} \right\}} \right\rbrack,{if}\, s(e) = 0,\quad s(e_{d}) = 1} \\
\end{array}\phantom{\}} \right.$$

The contribution to the likelihood for admission, discharge, surveillance test results and the in-situ event are summarized in [Table 2](#T2){ref-type="table"}.

2.3.. MCMC updates {#S5}
------------------

Parameters and augmented data were updated using Markov chain Monte Carlo (MCMC). Estimation within each iteration of the MCMC consisted of generating a new sample of both the augmented data and the model parameters.

To sample the augmented data, we sequentially stepped through each patient and proposed an initial colonization status and a sequence of times that the patient switched between being colonized and uncolonized. The proposal for the new augmented data depended on the transmission rates, clearance rates, and probability of importation. The newly proposed augmented data was then accepted according to standard Metropolis acceptance probability ([@R6]). Once the augmented data were updated, parameter values were proposed conditional on the observed data and the new augmented data. The parameter updates were accomplished via both Gibbs ([@R3]) and Metropolis-Hastings samples ([Table 1](#T1){ref-type="table"}) and updated sequentially. The process of updating the augmented data and parameter values was iterated and resulted in the posterior distribution for the parameters, which formed the basis for the analysis.

2.4.. Analysis {#S6}
--------------

We computed facility-specific estimates of posterior means for the model parameters, ranges and quartiles (Q1 -- Q3), as well as 95% credible intervals (95% CI), a Bayesian analogue to the confidence interval. Additionally, we reported median, quartiles and range for parameter estimates across the facilities. In addition to the parameter estimates obtained from the dynamic transmission model, we derived empirical estimates of admission and discharge prevalence to compare with the corresponding model-derived estimates. We defined empirical estimates of admission (discharge) prevalence as the percentage of admission (discharge) surveillance tests that were positive, where an admission (discharge) surveillance test occurred within 1 day of admission (discharge). In contrast to empirical estimates of prevalence, model-based estimates of prevalence were based on the estimated proportion of individuals colonized according to the underlying transmission model, and accounted for the imperfect nature of surveillance tests.

3.. Results {#S7}
===========

3.1.. Facility patient summaries {#S8}
--------------------------------

We analyzed 122 VA hospitals with 971,412 patients having 1,857,328 admissions and 3,525,837 MRSA surveillance tests, resulting in approximately 1.9 surveillance tests per admission. Additionally, we analyzed 111 nursing homes with 63,838 residents having 95,549 admissions and 188,425 MRSA surveillance tests corresponding with approximately 2.0 surveillance tests per admission. The median length of stay across all facilities was 5.1 days in hospitals and 45 days in nursing homes, and a high proportion of admission and discharge surveillance samples were taken from all admissions ([Table 3](#T3){ref-type="table"}). The median time between consecutive tests in hospitals was 2.5 days during an admission and 72 days between consecutive admissions (from discharge to readmission). In nursing homes, the median time between consecutive tests was 17 days during an admission and 10 days between consecutive admissions. The facilities included in this analysis represent a geographically diverse collection of facilities across the US.

3.2.. Transmission {#S9}
------------------

The median *baseline* transmission rate, or transmission rate at the beginning of the study in hospitals was 0.039 per day (Q1 -- Q3; 0.032 -- 0.050) and declined to 0.022 (0.016 -- 0.029) at the end of the study period, a reduction of 43.1% during approximately 3.5 years ([Fig. 1a](#F1){ref-type="fig"}). The majority of hospitals demonstrated a decreasing transmission rate parameter ([Fig. 1c](#F1){ref-type="fig"}); the 95% CI of the declining temporal trend term did not include zero in 59 hospitals (46%). In two (1.7%) facilities, the temporal trend term was increasing, with the lower bound of the 95% credible interval above zero.

Among nursing homes, the median *baseline* transmission rate was 0.009 per day (Q1 -- Q3; 0.005 -- 0.014) and remained stable at 0.010 (0.006 -- 0.015) after 2 years ([Fig. 1b](#F1){ref-type="fig"}). The temporal trend parameter for nursing homes was centered on zero, with a much flatter distribution than for hospitals. Inspection of the 95% credible intervals demonstrated that 10 (8.5%) had decreasing transmission and 7 (6.0%) increasing transmission.

3.3.. Prevalence {#S10}
----------------

All prevalence measures were substantially higher in nursing homes than in hospitals. The first-time admission prevalence, our "importation" parameter, had a median (range) of 10.5% (5.9%--18.4%) in hospitals and 18.7% (9.2%--37.4%) in nursing homes. Admission prevalence, which includes readmissions, was 12.5% (range: 7.1%--21.9%) in hospitals and 22.8% (13.2%--40.5%) in nursing homes. The average point prevalence was particularly high in nursing homes relative to hospitals, and exhibited a broader distribution ([Fig. 2b](#F2){ref-type="fig"}); median point prevalence (range) was 33.0% (12.0%--56.1%) and 17.1% (9.2%--41.6%), respectively, in the two types of facilities.

Model based estimates of admission prevalence and discharge prevalence were considerably higher than empirical estimates of admission and discharge prevalence in both hospitals and nursing homes ([Fig. 2a](#F2){ref-type="fig"}). The relative difference between empirical and model-based estimates ranged from 18% to 36%.

Admission prevalence was highly predictive of discharge prevalence in both hospitals and nursing homes ([Figs. 3a](#F3){ref-type="fig"} and [3b](#F3){ref-type="fig"}; correlation coefficients were 0.96 and 0.92, respectively). The mean difference between discharge prevalence and admission prevalence was higher in nursing homes than in hospitals: 6.1% and 1.1% respectively.

3.4.. Clearance rates and false negative {#S11}
----------------------------------------

The median (Q1-Q3) of the estimated mean time until loss of colonization (inverse of the clearance rate) was 40.1 (30.1--54.5) days during an acute care facility hospitalization and 274.0 (237.7--330.0) days during the period between consecutive stays. For long-term care facility residents, median estimated time to clearance was 215.4 (142.0--279.1) days during their stay, and 108.1 (44.3--191.0) days in the period between consecutive stays. We estimated the median (Q1-Q3) false negative probability to be 23.5% (19.5%--26.6%) among hospitals and 21.8% (16.6%--25.9%) among nursing homes.

4.. Discussion {#S12}
==============

We fit Bayesian models to VA health system data to estimate the key mechanistic parameters that govern the epidemiology of resistant bacteria in healthcare settings. Our findings demonstrate that transmission dynamics in nursing homes and hospitals are distinctly different. The transmission rate parameter, which represents the linear relationship between colonization prevalence and rate of new colonizations, was substantially lower in nursing homes than in hospitals. Stated a different way, MRSA cases in nursing homes were less infectious per day than those in hospitals, a finding that has potential implications for design and implementation of control policies ([@R18]). Interventions that address the cumulative risk of transmission across longer time scales may be particularly beneficial in nursing homes. Heterogeneity in the transmission rate parameter across facilities may also serve as a useful facility-level surrogate for quality of infection control practices. However, the transmission rate parameter may also be affected by patient factors, such as antibiotic use, that influence susceptibility of acquisition as well as bacterial shedding.

One of the key goals of this study was to improve understanding of the impact of VA's MRSA prevention initiative. Our results demonstrate that the median transmission rate parameter progressively declined in VA hospitals but not in VA nursing homes. Moreover, within the population of hospitals, the temporal trends in transmission rate parameters were highly heterogeneous. Further studies to identify which facility characteristics predict transmission trends over time may shed light on the factors that influence success of the MRSA prevention initiative.

Another finding was that the estimated MRSA clearance rate was much lower in nursing homes than in hospitals. The apparent reduction in rate of MRSA clearance in nursing homes may partially be due to the decreased intensity of exposure to anti-MRSA antibiotics (e.g., vancomycin) compared to hospitals (unpublished data). In order to estimate clearance, collection of surveillance tests after a positive test is necessary. In general, since the model denotes that negative tests after a positive test represent either clearance or a false negative, the higher the fraction of such tests that are positive, the lower the estimated clearance rate. It is important to acknowledge that the effect of antibiotics may be to suppress positive test results, without necessarily eradicating MRSA, a difference that our model cannot distinguish.

Admission prevalence, discharge prevalence, and average prevalence are three types of prevalence that are relevant to healthcare epidemiology. Typically, prevalence is estimated directly from the proportion of surveillance tests that are positive, within a time window defined according to the type of prevalence (e.g., for admission prevalence, tests collected within 24 h of admission). Because of false negativity, this approach yields an underestimate of true prevalence. Bias may also arise because of sample selection and test timing. For example, a test obtained 24 h after admission may not reflect true admission status; similarly, tests obtained prior to discharge may not reflect true discharge status.

Our methods addressed these biases in estimation of these quantities and again demonstrated important distinctions between hospitals and nursing homes. In both types of facilities, admission prevalence was a very strong predictor of discharge prevalence. However, admission prevalence was much higher in nursing homes than hospitals. We note that a much higher proportion of long-term care facility patients had prior healthcare facility exposure. Moreover, the difference between discharge prevalence and admission prevalence was substantially higher in nursing homes. The combination of high admission prevalence, reduced clearance, and increased length of stay elevated MRSA prevalence in nursing homes relative to hospitals, compensating for the comparatively lower transmission rate parameter.

Our study design and analytical approach had notable strengths. Fitting dynamic statistical models to MRSA surveillance data make it feasible to explore epidemiological mechanisms that influence disease spread. A key limitation was the simplifying assumption that there were only two infection states, namely colonized and uncolonized. This assumption meant we were unable to differentiate between patients who were truly uncolonized, and those who were exposed or colonized but undetectable due to low-level colonization. An additional limitation is that we were unable to explicitly incorporate information on adherence to contact precautions, antimicrobial exposure and other factors that may have influenced transmission. For example, adherence to contact precautions may be correlated with surveillance test compliance. If so, less compliant facilities could have implemented contact precautions with lower adherence. Additionally, adherence to contact precautions could have changed over time during the study, either improving or waning, due to an initial resistance to the policy or an increasing complacency over time. Not explicitly accounting for adherence to contact precautions could lead to some bias. Finally, both the VA patient population and the VA Healthcare System may not be representative of other US hospitals and settings, and the findings of this study with respect to trend and variation in epidemiological dynamics may not be generalizable to the entire United States. A fundamental challenge in designing and implementing infection control interventions is their high resource utilization. Modeling and forward simulation can provide preliminary evidence on the effectiveness of interventions while accounting for indirect effects, and may identify important limitations or optimal implementation strategies earlier, leading to more cost-effective intervention implementations ([@R5]). In order for forward simulations to reliably predict the impact of intervention strategies, it is critical that their predictions be consistent with observed data, and in particular that the parameter value inputs for the simulation are precisely estimated from data. We have estimated the variability of key mechanistic parameters across a broad range of facilities, and these parameters can be used to test the sensitivity of intervention effects across a wide range of realistic settings.

A facility connected to other facilities via patient transfer or readmission may serve as a source of antibiotic resistance, sustaining transmission across a region ([@R20]). Our future extensions of this work will allow for tracking readmissions and transfers across multiple facilities and improve our understanding of key factors for controlling regional transmission of antibiotic resistance. Additionally, we plan to incorporate detailed patient and facility characteristics and to test mechanistic hypotheses to better understand specific mechanisms and factors, including progression to clinical infection, that are most important for driving transmission and infection within and across a network of healthcare facilities.
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![The top panel shows the estimated temporal trend of the median (---quartiles) for the transmission rate parameter in a) hospitals and b) nursing homes during the study period, The bottom panel shows c) the distribution of the estimated relative change in transmission in hospitals and nursing homes.](nihms-1538847-f0001){#F1}

![Shows a) comparison of distributions for admission prevalence and discharge prevalence in hospitals, and nursing homes, shaded gray. Comparison is between those estimates derived from the Bayesian transmission model and those estimated empirically, based on the proportion of positive admission or discharge surveillance tests, and b) the variation and differences in the distribution of facility prevalence within and between hospitals and nursing homes.](nihms-1538847-f0002){#F2}

![Scatterplots indicate the strength of the relationship between model-based estimates of admission prevalence and discharge prevalence in a) hospitals, and b) nursing homes. Model-based prevalence estimates are the estimated proportion of patients (residents) who are colonized at admission and discharge.](nihms-1538847-f0003){#F3}

###### 

Transmission Model Parameters and Markov Chain Monte Carlo Sampling Distribution.

  Parameters   Description                               MCMC Update ^[\*](#TFN1){ref-type="table-fn"}^   Prior distribution
  ------------ ----------------------------------------- ------------------------------------------------ --------------------
  *σ*          In-situ probability                       Gibbs                                            Beta
  *ν*          First-admission importation probability   Metropolis-Hastings                              Log-Normal
  *γ*          Out-of-unit clearance rate                Metropolis-Hastings                              Gamma
  *λ~I~*       Transmission rate log-linear intercept    Metropolis-Hastings                              Normal
  *λ~S~*       Transmission rate log-linear slope        Metropolis-Hastings                              Normal
  *η*          In-unit clearance rate                    Gibbs                                            Gamma
  *Φ*          Surveillance test false negative          Gibbs                                            Beta

**MCMC** = Markov chain Monte Carlo.

###### 

Contribution of Event-Specific Probabilities to the Transmission Model Likelihood.

  Event                        Contribution to likelihood - *g*(*e*; *θ*)
  ---------------------------- --------------------------------------------
  In-situ                      σ^*s*(*e*)^(1 -- *σ*)^1--*s*(*e*)^
  Clearance                    *η*
  Negative surveillance test   *Φ*^*s*(*e*)^
  Positive surveillance test   1 -- *Φ*^*s*(*e*)^
  Admission and discharge      1

###### 

Summaries of Hospitals, Nursing Homes and Admissions from Veterans Affairs Facilities in the United States.

  Factor                                                         Acute Care             Long-term care
  -------------------------------------------------------------- ---------------------- ----------------------
  Mean LOS (days) *median (Q1-Q3)*                               5.1 (4.3--6.0)         45 (38--63)
  Mean \# patients *median (Q1-Q3)*                              62 (29--99)            71 (50--104)
  Fraction admission tests *median (Q1-Q3)*                      0.91 (0.86--0.94)      0.80 (0.71--0.86)
  Fraction discharge tests *median (Q1-Q3)*                      0.85 (0.76--0.89)      0.76 (0.66--0.83)
  Tests per admission *median (Q1-Q3)*                           1.9 (1.8--2.1)         2.0 (1.8--2.1)
  Percent of admissions that are readmissions *median (Q1-Q3)*   46.7% (42.5%--49.6%)   31.7% (26.3%--37.3%)
  Region *no. (%)*                                               122 (100%)             111 (100%)
  West                                                           23 (19%)               19 (17%)
  Midwest                                                        30 (25%)               27 (24%)
  South                                                          48 (39%)               41 (37%)
  Northeast                                                      21 (17%)               24 (22%)
